trending Market Intelligence /marketintelligence/en/news-insights/trending/d3foth1mukoobn-bd6mzjg2 content esgSubNav
In This List

Acerus Pharmaceuticals names CEO

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Acerus Pharmaceuticals names CEO

Acerus Pharmaceuticals Corp. appointed Edward Gudaitis as president and CEO, effective May 1.

Luc Mainville will continue to act as interim CEO of the company and work with Gudaitis to ensure a smooth transition.

Following the transition, Mainville will resume his position as a board member.

Gudaitis most recently served as vice president and general manager of Allergan PLC's Allergan Canada.